Company Background and Bankruptcy History

HearUSA was founded in 1986-1987 as HEARx by physician-entrepreneur Paul A. Brown, MD. The company operated as a publicly traded hearing aid retailer before filing Chapter 11 bankruptcy in 2011.

Siemens Hearing Instruments acquired HearUSA out of bankruptcy. Siemens later became Sivantos, which merged with Widex in March 2019 to form WS Audiology (WSA). WSA is privately held with approximately 51% ownership by the Tøpholm and Westermann families and the Lundbeck Foundation (via CN8 A/S), plus approximately 49% held by EQT Partners and ATHOS KG.

The 2022 Brand Consolidation

In October 2022, WSA consolidated 28 different regional retail brands under the unified HearUSA name. This included launching "Centers of the Future" concept stores. Before the consolidation, you might have seen HearUSA-owned centers operating under various regional names; the rebrand was meant to create a single national identity.

The AARP Transition - Critical Correction

For roughly 14 years (~2008 until November 2022), HearUSA administered the AARP Hearing Care Program. AARP members got discounts on hearing aids through HearUSA's network.

In November 2022, the AARP relationship transferred from HearUSA to UnitedHealthcare Hearing. The current program is officially branded "AARP Hearing Solutions™ provided by UnitedHealthcare Hearing."

HearUSA confirmed the change to industry publication Soundly: "While we no longer manage AARP's hearing program, we are a participating provider in their new program."

This means:

• HearUSA is NOT the current AARP hearing aid partner
• HearUSA IS a participating provider within the UHC Hearing network that powers the new AARP program
• AARP members can still use HearUSA centers, but the program is now administered by UHC, not HearUSA

Older content sources from before November 2022 that describe HearUSA as "the AARP hearing aid partner" are now incorrect.

US Footprint and Business Model

HearUSA operates 380+ corporate-owned hearing centers across most US states, with no coverage in Alabama, Mississippi, Arkansas, or Idaho. The model is all corporate, no franchises - a structural difference from Miracle-Ear, Beltone, and Audibel, which are franchise-dominant.

Corporate ownership means more consistent service standards, pricing, and product availability across HearUSA centers compared to franchise networks where local owners set policies within brand guidelines.

Hearing Aid Products - WSA Vertical Integration

HearUSA dispenses primarily Signia, Widex, and Rexton - all WS Audiology brands manufactured by its own parent company. Other manufacturer products (Phonak, Oticon, ReSound, Starkey) can sometimes be ordered but are not stocked.

Sony OTC Distribution

HearUSA is one of the only major chain retailers stocking Sony OTC hearing aids:

• Sony CRE-E10 (rechargeable, premium): $1,299.99 per pair
• Sony CRE-C10 (battery, mid-tier): $999.99 per pair

Disclosure note: Sony OTC products are also WSA-manufactured. WSA produces the underlying hardware that Sony brands and markets. So even when buyers think they're buying "Sony OTC" from HearUSA, they're ultimately buying WSA products through WSA's own retail chain.

Same-Day Fitting Service

HearUSA promotes "Hear Better Today" / "Test, Advise, Fit and Go" - meaning audiogram testing and hearing aid fitting can be completed in a single visit. This is a meaningful service differentiator from chains requiring multiple appointments.

Pricing Structure

HearUSA pricing ranges from approximately $2,000 to $8,400 per pair:

• Basic Digital tier: ~$2,538 per pair
• Premium tier: ~$8,400 per pair

Pricing is bundled with the HearUSA Loyalty Club 3-year service program (purchases after April 3, 2023).

Price Match Guarantee

HearUSA offers a price match guarantee - but it explicitly excludes:

• Costco Hearing Aid Centers
• Online retailers (DTC channels like Eargo, Lexie, Jabra Enhance)
• Insurance pricing

This means the price match guarantee primarily applies to other independent audiology clinics - not to the most price-competitive channels in the market.

Insurance Acceptance

HearUSA works with 85+ insurance plans including Kaiser Permanente. This makes it relatively accessible for buyers using insurance benefits, though typical insurance allowances ($1,500-$2,500 per ear) often leave substantial out-of-pocket costs against HearUSA pricing.

Trial Period, Warranty, and Service

• Trial period: 60-day risk-free trial (45 days for Sony OTC) - better than HearingLife's 30 days, weaker than Costco's 180 days
• Warranty: Bundled within the HearUSA Loyalty Club 3-year service program

Reputation Flags

BBB and Consumer Reviews

• BBB: Two not-accredited corporate BBB profiles (FL HQ and Grove City OH)
• Trustpilot: Tiny sample size, leans negative
• Yelp brand aggregate: 3.2/5 across 632 reviews / 253 listed locations
• Consumer Reports overall score: 62 - 15th of 17 retailers ranked, partly due to limited 3-brand selection

Recurring Complaint Themes

• Inflated pricing for insured customers (especially Kaiser allowance exhaustion patterns)
• Audiologist turnover replaced by HIS staff (declining clinical credentials at some centers)
• Store closures inconveniencing seniors who had relationships at consolidated locations
• Sales pressure during initial consultations

No major FTC enforcement actions or class actions have been identified specifically against HearUSA as of April 2026.

Who Should Consider HearUSA

• Buyers who specifically want Signia, Widex, or Rexton prescription hearing aids and prefer the HearUSA retail relationship
• Buyers who value the same-day fitting service model
• Buyers with insurance benefit networks that include HearUSA (especially Kaiser Permanente)
• Buyers who want to see Sony OTC products in person at retail (HearUSA is one of few chains carrying them)

Who Should Probably Look Elsewhere

• Buyers who want multi-brand selection - HearUSA is essentially WSA-only (Signia, Widex, Rexton)
• Buyers seeking the longest trial periods (Costco 180 days)
• Buyers in AL, MS, AR, or ID where HearUSA does not operate
• Buyers expecting AARP-specific HearUSA discounts (program now administered by UHC, not HearUSA)
• Buyers with mild-to-moderate hearing loss for whom OTC alternatives may be appropriate

Considering OTC As An Alternative?

If your hearing loss is mild-to-moderate (which describes roughly 70% of adult-onset hearing loss), the FDA OTC framework created in October 2022 means you have legitimate options below the prescription clinic price tier. OTC hearing aids range from approximately $200 to $2,950 per pair, with FDA regulation enforcing safety standards on output, labeling, and product claims. The clinical difference between quality OTC and prescription hearing aids for mild-to-moderate loss is often smaller than the price difference suggests.

For severe-to-profound hearing loss, OTC is not appropriate and prescription is genuinely necessary. The right path depends on your audiogram, not on any one chain's marketing.

Read more: OTC vs Prescription Hearing Aids - Honest Comparison · How Much Do Hearing Aids Cost in 2026?